Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ICON plc announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and ...
read more
OSE Immunotherapeutics and Cenexi, a French contract development and manufacturing organization (CDMO), announced the signature of an agreement whereby Cenexi will manufacture clinical batches of CoVepiT, OSE Immunotherapeutics' vaccine candidate ...
read more
NewAge Industries, the manufacturer of AdvantaPure® high purity tubing products, has expansion plans underway – again – at its corporate facility in southeastern Pennsylvania. The project will add over 3,000 sq. ft. of ISO Class 7 certified ...
read more
LGM Pharma announced new Analytical Services that provide analytical testing and stability services to pharmaceutical developers and manufacturers, including compounding pharmacies. The company is offering its analytical services expertise and ...
read more
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a partnership with VectorBuilder, a vector design, optimization and manufacturing company. Univercells ...
read more
SRI International (SRI) announced a drug discovery research collaboration with Sanofi. By leveraging SRI’s SynFini™ platform, an artificial intelligence (AI)-guided, automated synthetic-chemistry system, the collaboration will discover and develop ...
read more
The acquisition of Pharmatech supports USPs commitment to strengthen the supply chain of quality medicines, builds on our longstanding work with regulators and manufacturers globally to solve some of the most critical and challenging problems in the ...
read more
Blue Water Vaccines announced a novel virus-like particle (VLP) vaccine platform from Cincinnati Children's Hospital Medical Center (Cincinnati Children's). The platform utilizes nanoparticle delivery technology that has the potential for broad ...
read more
SP Scientific Products (SP) announces that to stay ahead of the ever-increasing global demand for its state-of-the-art fill-finish and lyophilization (freeze dryer) equipment, it has more than doubled its worldwide manufacturing capacity. Central to ...
read more
Curia, formerly AMRI, agreed to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with facilities in California, Massachusetts, and Texas. LakePharma uses technology ...
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, agreed to acquire Integrity Bio Inc, a privately held formulation and fill-finish organization headquartered in Camarillo, California.
read more
Inotiv, a research organization specializing in nonclinical and analytical drug discovery and development services, acquired genetic toxicology assets from MilliporeSigma’s BioReliance® portfolio, including standard operating procedures, stock ...
read more
Albany Molecular Research, a contract research development and manufacturing organization, announced that it is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s strategic positioning as an end-to-end global ...
read more
DFE Pharma, a global leader in pharmaceutical excipient solutions, is excited to announce the launch of a new addition to its broad excipient portfolio, Pharmacel® sMCC 90, a silicified microcrystalline cellulose (MCC).
read more
Rho, a full-service contract research organization, promoted healthcare veteran Jack Modell, MD, to the post of Chief Medical Officer. Rho helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical ...
read more